Monthly Archives: November 2012

Quebec Increases Refundable SR&ED Tax Credit for Biopharmaceutical Companies

The Parti Quebecois government has tabled a 2013-2014 fall budget, which has increased the refundable SR&ED tax credit for the biopharmaceutical sector.   The basic refundable tax credit rate of 17.5% will be temporarily increased to 27.5% for eligible biopharmaceutical … Continue reading

Posted in Changes to SR&ED | Tagged , , , | Leave a comment

Alberta Corporate Tax Amendment Act Introduced to Remove “the Grind” from SR&ED

Because of the scheduled legislation to remove “the Grind” from Alberta SR&ED claims this fall, the Alberta Corporate Tax Act will be amended to address the forthcoming technical changes.  As a result, AT1 Schedule 9 has been revised and be … Continue reading

Posted in Changes to SR&ED, Filing for SR&ED | Leave a comment

Reduction of SR&ED Tax Credit Detrimental to Canadian Businesses

Many of Canada’s largest research and development have voiced their concerns over the federal government’s cuts to the SR&ED program.  According to a report by Canadian Manufacturers and Exporters (CME),  Canadian businesses will receive a $750-million / year reduction in … Continue reading

Posted in Changes to SR&ED | Tagged | Leave a comment